CHO Pharma, Inc. (TPEX: 6586)
Taiwan
· Delayed Price · Currency is TWD 51.40
+0.50 (0.98%)
Jan 21, 2025, 2:57 PM CST
CHO Pharma Revenue
CHO Pharma had revenue of 1.08M TWD in the half year ending June 30, 2024. This brings the company's revenue in the last twelve months to 1.08M, up 1,703.33% year-over-year.
Revenue (ttm)
1.08M
Revenue Growth
+1,703.33%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
11.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 60.00K | -3.51M | -98.32% |
| Dec 31, 2021 | 3.57M | 3.43M | 2,486.96% |
| Dec 31, 2020 | 138.00K | -159.00K | -53.54% |
| Dec 31, 2019 | 297.00K | 7.00K | 2.41% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Caliway Biopharmaceuticals | 49.98M |
| Bora Pharmaceuticals Co., LTD. | 16.71B |
| Lotus Pharmaceutical | 17.59B |
| Lumosa Therapeutics | 37.82M |
| Oneness Biotech | 112.20M |
| Polaris Group | 75.65M |
| Center Laboratories | 1.57B |